The MMRF Blog - Multiple Myeloma Research Foundation

The MMRF Blog

Statement from Walter M. Capone, President and CEO of the Multiple Myeloma Research Foundation (MMRF) Regarding the Decision by the U.S. Food and Drug Administration (FDA) to Approve Empliciti™ (elotuzumab), for the treatment of people with multiple myeloma who have received one to three prior medications

"The approval of elotuzumab marks another important milestone in the treatment of multiple myeloma in a short period of time. Since 2008, the Multiple Myeloma Research Consortium (MMRC), MMRF’s clinical network, has been a key partner in the development of elotuzumab, assisting in the initiation of four clinical trials, including one that led to the pivotal Phase III ELOQUENT-2 study which supported this approval of elotuzumab..." READ MORE

Posted: November 30, 2015

Statement from Walter M. Capone, President and CEO of the Multiple Myeloma Research Foundation (MMRF) Regarding the Decision by the U.S. Food and Drug Administration (FDA) to Approve Ninlaro® (ixazomib) in Combination with Two Other Therapies to Treat People with Multiple Myeloma Who Have Received At Least One Prior Therapy

“The field of cancer treatment, and multiple myeloma in particular, has never seen a watershed moment like this. With two breakthrough designation drug approvals in the treatment of multiple myeloma in the last week, including today’s approval of ixazomib, the transformation in the treatment of myeloma is clearly underway..." READ MORE

Posted: November 20, 2015

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.

Giralt S, Garderet L, Durie B, Cook G, Gahrton G, Bruno B, Hari P, Lokhorst H, McCarthy P, Krishnan A, Sonneveld P, Goldschmidt H, Jagannath S, Barlogie B, Mateos M, Gimsing P, Sezer O, Mikhael J, Lu J, Dimopoulos M, Mazumder A, Palumbo A, Abonour R, Anderson K, Attal M, Blade J, Bird J, Cavo M, Comenzo R, de la Rubia J, Einsele H, Garcia-Sanz R, Hillengass J, Holstein S, Johnsen HE, Joshua D, Koehne G, Kumar S, Kyle R, Leleu X, Lonial S, Ludwig H, Nahi H, Nooka A, Orlowski R, Rajkumar V, Reiman A, Richardson P, Riva E, San Miguel J, Turreson I, Usmani S, Vesole D, Bensinger W, Qazilbash M, Efebera Y, Mohty M, Gasparreto C, Gajewski J, LeMaistre CF, Bredeson C, Moreau P, Pasquini M, Kroeger N, Stadtmauer E. Biol Blood Marrow Transplant. 2015 Dec;21(12):2039-51. doi: 10.1016/j.bbmt.2015.09.016. Epub 2015 Sep 30. Review. PMID: 26428082 [PubMed - in process] READ MORE

Posted: November 19, 2015

Page 39 of 87« First...102030...3738394041...506070...Last »